Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.

Professor Clare Verrill using the new AI pathology software

Researchers and clinicians in Oxford have begun an evaluation of artificial intelligence (AI) software that could help pathologists diagnose prostate cancer.

Testing of the technology in a clinical setting, which is under way at Oxford University Hospitals (OUH) NHS Foundation Trust, is a key milestone in the University of Oxford-led ARTICULATE PRO study.

This two-year project, funded by an AI in Health and Care Award from the NHS AI Lab in partnership with the Accelerated Access Collaborative, aims to investigate the deployment of AI in the prostate cancer pathway by using Paige Prostate, computer-assisted diagnostic system that aims to help pathologists detect, grade and measure tumours in prostate biopsies, or tissue samples.

OUH pathologists are using the AI applications to help read prostate biopsy slides as part of their routine work. The technology should flag suspicious areas to pathologists immediately by identifying the hallmarks of malignant cells captured by previous training in large datasets of biopsies. It also assesses the amount of tumour present and how aggressive it appears.

The project is led by OUH Cellular Pathology Consultant and Nuffield Department of Surgical Sciences Associate Professor Clare Verrill, an expert urological histopathologist. She leads a multi-disciplinary team of clinical and non-clinical colleagues, including three patient representatives.   

Read the full story on the Nuffield Department of Surgical Sciences website